Veon (VEON) EPS (Weighted Average and Diluted) (2009 - 2025)

Veon has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at $1.5 million in Q2 2025.

• For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) rose 57.05% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2025 stood at $1.5 million (up 57.05% YoY), and the FY2025 full-year result was $0.3, up 30.43% from the prior year.
• EPS (Weighted Average and Diluted) for Q2 2025 stood at $1.5 million, up from $971428.6 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $1.5 million in Q2 2025, with the low at $714.29 in Q2 2021.
• Historically, EPS (Weighted Average and Diluted) has averaged $500085.0 across 5 years, with a median of $1762.5 in 2022.
• Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) plunged 50.15% — and 2024, when it surged 110469.11%.
• Veon's EPS (Weighted Average and Diluted) stood at $714.29 in 2021, then soared by 146.75% to $1762.5 in 2022, then sank by 50.15% to $878.57 in 2023, then surged by 110469.11% to $971428.6 in 2024, then surged by 57.05% to $1.5 million in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $1.5 million (Q2 2025), $971428.6 (Q2 2024), and $878.57 (Q2 2023), per Business Quant data.